Close Menu

In 1990, members of the Havasupai tribe in Arizona gave researchers at Arizona State University some DNA samples in order to see if the scientists could find a cause for the tribe's high incidence of diabetes. But, as the New York Times' Amy Harmon reports, the tribe sued when they found out that the geneticists were also using the blood samples to study mental illness and theories of the tribe's geographical origins.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.